Injection site reactions are more common with amylin analogs, and the dual-mechanism approach means managing two sets of potential adverse effects
The Specialist Pharmacy Service (SPS) and NHS practice guidance advise that when a GLP-1 receptor agonist is introduced, any DPP-4 inhibitor should generally be discontinued due to the mechanistic overlap and lack of additive benefit
The USA demonstrates 24.0% growth, prioritizing innovation in diabetes and advanced pharmaceutical development
For patients, improved access to effective weight-loss medications could lead to better health outcomes, enhanced quality of life, and reduced risk of chronic conditions such as diabetes, hypertension, and heart disease
Additionally, researchers also discovered that study participants experienced a drop in their Migraine Disability Assessment Test scores by 32 points
This approach enhances accessibility to health care services, especially during remote or challenging circumstances